Delayed Puberty in Boys; Clinical and Biochemical Characteristics and Effect of Testosterone Treatment
NCT02034487 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 451
Last updated 2014-01-13
Summary
To evaluate the phenotype and biochemical characteristics of boys referred for delayed puberty, to describe the frequency of associated co-morbidities and diseases, to evaluate the diagnostic criteria and the effect of testosterone treatment.
Conditions
- Delayed Puberty
Interventions
- OTHER
-
retrospective data collection
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Anders Juul, PhD, DMSc · Rigshospitalet, Denmark
Eligibility
- Min Age
- 13 Years
- Max Age
- 20 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1990-01-31
- Primary Completion
- 2013-02-28
- Completion
- 2013-10-31
Countries
- Denmark
Study Locations
More Related Trials
-
Purification of Testis-Stimulating Factor in Precocious Puberty
NCT00004344 ·Status: COMPLETED
-
Evaluation of Testosterone Nasal Gel in Hypogonadal Boys
NCT03345797 ·Status: TERMINATED ·Phase: PHASE1
-
Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
NCT00094328 ·Status: COMPLETED ·Phase: PHASE2
-
Testosterone Treatment in a Patient With 17β-hydroxysteroid Dehydrogenase Type 3 Deficiency: an N-of-1 Study
NCT04831099 ·Status: UNKNOWN ·Phase: PHASE3
-
Klinefelter Syndrome and Testosterone Treatment in Puberty
NCT06294990 ·Status: RECRUITING ·Phase: PHASE4
-
Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males
NCT03541395 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Pharmacokinetics and Safety of Testosterone
NCT01370369 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors
NCT02419105 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815)
NCT00254553 ·Status: TERMINATED ·Phase: PHASE2
-
Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure
NCT00957034 ·Status: TERMINATED ·Phase: PHASE2
-
Benefit of the Treatment With Testosterone in Chronic Heart Failure Testosterone Deficiency Subjects
NCT01813201 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
NCT01403116 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome
NCT01585831 ·Status: COMPLETED ·Phase: NA
-
Pubertal Induction in Individuals With Hypogonadism
NCT02871986 ·Status: UNKNOWN
-
Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer Survivors
NCT02240966 ·Status: COMPLETED
-
Does Testosterone Improve Function in Hypogonadal Older Men
NCT00304213 ·Status: WITHDRAWN ·Phase: PHASE4
-
Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial
NCT02418572 ·Status: TERMINATED ·Phase: PHASE3
-
Diurnal Testosterone Concentration
NCT03091296 ·Status: COMPLETED
-
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
NCT02149264 ·Status: COMPLETED ·Phase: PHASE3
-
Testosterone Treatment for Hypogonadal Men
NCT00433199 ·Status: COMPLETED ·Phase: PHASE3
-
Testosterone Therapy in Heart Failure
NCT01377103 ·Status: WITHDRAWN ·Phase: NA
-
Open-Label Study of ARD-0403 in Testosterone Deficient Men
NCT00448955 ·Status: COMPLETED ·Phase: PHASE3
-
Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome
NCT00134745 ·Status: COMPLETED ·Phase: PHASE4
-
Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
NCT00431197 ·Status: COMPLETED ·Phase: PHASE1
-
Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone
NCT03484260 ·Status: COMPLETED